Get the Stockscreener App
0.061
1.50%
0.0009
After Hours:
.08
0.019
+31.15%
Medipharm Labs Corp Stock (MEDIF) Forecast
The Medipharm Labs Corp (MEDIF) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.0141, representing a -76.89% decrease from the current price of $0.061. The highest analyst price target is $0.0196, and the lowest is $0.00856.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MEDIF Price Target
Average 0.0117
(-80.80% Downside)
Long-term MEDIF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Medipharm Labs Corp financial reports and earnings history, Medipharm Labs Corp (MEDIF) stock could reach $0.102 by 2030, $0.3255 by 2040 and $0.4836 by 2050. See the projected annual prices until 2050 of the Medipharm Labs Corp stock below:
- Medipharm Labs Corp (MEDIF) is expected to reach an average price of $0.2096 in 2035, with a high prediction of $0.2166 and a low estimate of $0.2205. This indicates an $243.68% rise from the last recorded price of $0.061.
- Medipharm Labs Corp (MEDIF) stock is projected to chart a bullish course in 2040, with an average price target of $0.335, representing an $449.23% surge from its current level. The forecast ranges from a conservative $0.328 to a sky-high $0.3255.
- Our analysts predict Medipharm Labs Corp (MEDIF) to jump 611.64% by 2045, soaring from $0.3734 to an average price of $0.4341, potentially reaching $0.4481. While $0.3734 is the low estimate, the potential upside is significant.
- Medipharm Labs Corp (MEDIF) stock is expected to climb by 2050, reaching an average of $0.478, a $683.60% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.4836 and $0.4724, respectively, highlighting the market's uncertainty.
Medipharm Labs Corp Stock (MEDIF) Year by Year Forecast
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2025
Medipharm Labs Corp Stock (MEDIF) is expected to reach an average price of $0.013 in 2025, with a high prediction of $0.026 and a low estimate of $0.000001. This indicates an -78.67% fall from the last recorded price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.00151 | $0.00856 | $0.0196 | -97.53% |
| June, 2025 | $0.00483 | $0.00838 | $0.0115 | -92.08% |
| July, 2025 | $0.00664 | $0.00208 | $0.00336 | -89.11% |
| August, 2025 | $0.0086 | $0.000097 | $0.0167 | -85.91% |
| September, 2025 | $0.00349 | $0.000001 | $0.0159 | -94.27% |
| October, 2025 | $0.0177 | $0.0039 | $0.0107 | -71.04% |
| November, 2025 | $0.0144 | $0.0186 | $0.0133 | -76.34% |
| December, 2025 | $0.016 | $0.0181 | $0.0131 | -73.69% |
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2026
The predicted value for Medipharm Labs Corp (MEDIF) in 2026 is set at an average of $0.0179. Estimates vary from a peak of $0.0336 to a trough of $0.0023, indicating an -70.59% surge from the present price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0154 | $0.0116 | $0.00779 | -74.76% |
| February, 2026 | $0.00294 | $0.0023 | $0.00684 | -95.18% |
| March, 2026 | $0.0282 | $0.00893 | $0.0135 | -53.83% |
| April, 2026 | $0.0217 | $0.0287 | $0.0234 | -64.44% |
| May, 2026 | $0.0224 | $0.0289 | $0.023 | -63.24% |
| June, 2026 | $0.0255 | $0.0211 | $0.0181 | -58.16% |
| July, 2026 | $0.0097 | $0.0182 | $0.0132 | -84.09% |
| August, 2026 | $0.0245 | $0.0114 | $0.0241 | -59.76% |
| September, 2026 | $0.0381 | $0.0248 | $0.0286 | -37.48% |
| October, 2026 | $0.0343 | $0.0388 | $0.0336 | -43.72% |
| November, 2026 | $0.0352 | $0.0376 | $0.0329 | -42.26% |
| December, 2026 | $0.034 | $0.0306 | $0.0268 | -44.29% |
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Medipharm Labs Corp (MEDIF) is $0.0372, with a high forecast of $0.0539 and a low forecast of $0.0205. This indicates an -39.04% decrease from the last price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.021 | $0.0205 | $0.0224 | -65.65% |
| February, 2027 | $0.0264 | $0.0268 | $0.0347 | -56.80% |
| March, 2027 | $0.0419 | $0.0489 | $0.0438 | -31.35% |
| April, 2027 | $0.042 | $0.0485 | $0.0428 | -31.10% |
| May, 2027 | $0.0444 | $0.0401 | $0.0376 | -27.21% |
| June, 2027 | $0.028 | $0.0365 | $0.0316 | -54.09% |
| July, 2027 | $0.052 | $0.0295 | $0.0453 | -14.75% |
| August, 2027 | $0.0586 | $0.0457 | $0.0491 | -3.91% |
| September, 2027 | $0.0542 | $0.059 | $0.0539 | -11.11% |
| October, 2027 | $0.0508 | $0.057 | $0.0526 | -16.80% |
| November, 2027 | $0.0526 | $0.0496 | $0.0458 | -13.81% |
| December, 2027 | $0.039 | $0.0386 | $0.0409 | -36.13% |
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2028
In 2028, Medipharm Labs Corp (MEDIF) is projected to reach an average price of $0.0609, with a high projection of $0.0771 and a low estimate of $0.0447. This indicates an -0.19% fall from the last price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0697 | $0.0447 | $0.0559 | +14.25% |
| February, 2028 | $0.0621 | $0.0691 | $0.0641 | +1.74% |
| March, 2028 | $0.0616 | $0.0681 | $0.0625 | +1.04% |
| April, 2028 | $0.0554 | $0.0592 | $0.0571 | -9.25% |
| May, 2028 | $0.0463 | $0.0548 | $0.0533 | -24.09% |
| June, 2028 | $0.0732 | $0.0477 | $0.0665 | +20.00% |
| July, 2028 | $0.0791 | $0.0666 | $0.0696 | +29.65% |
| August, 2028 | $0.0741 | $0.0792 | $0.0742 | +21.51% |
| September, 2028 | $0.0701 | $0.0765 | $0.0724 | +14.86% |
| October, 2028 | $0.0712 | $0.0687 | $0.0649 | +16.67% |
| November, 2028 | $0.057 | $0.0568 | $0.0593 | -6.60% |
| December, 2028 | $0.0682 | $0.0625 | $0.0771 | +11.76% |
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2029
The 2029 price forecast for Medipharm Labs Corp Stock (MEDIF) is $0.0853 on average, with a high prediction of $0.1047 and a low estimate of $0.0658. This represents an +39.82% increase from the previous price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0822 | $0.0893 | $0.0844 | +34.83% |
| February, 2029 | $0.0812 | $0.0877 | $0.0823 | +33.18% |
| March, 2029 | $0.0744 | $0.0782 | $0.0765 | +21.94% |
| April, 2029 | $0.0646 | $0.0731 | $0.0722 | +5.91% |
| May, 2029 | $0.0944 | $0.0658 | $0.0877 | +54.75% |
| June, 2029 | $0.097 | $0.0875 | $0.0831 | +59.04% |
| July, 2029 | $0.094 | $0.0994 | $0.0946 | +54.13% |
| August, 2029 | $0.0894 | $0.096 | $0.0921 | +46.53% |
| September, 2029 | $0.0779 | $0.0877 | $0.0839 | +27.66% |
| October, 2029 | $0.075 | $0.0749 | $0.0777 | +22.93% |
| November, 2029 | $0.0891 | $0.0804 | $0.0983 | +46.03% |
| December, 2029 | $0.1024 | $0.1095 | $0.1047 | +67.92% |
Medipharm Labs Corp Stock (MEDIF) Price Forecast for 2030
Medipharm Labs Corp Stock (MEDIF) is expected to reach an average price of $0.1045 in 2030, with a high forecast of $0.1251 and a low forecast of $0.084. This signifies an +71.37% surge from the last price of $0.061.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1008 | $0.1073 | $0.102 | +65.32% |
| February, 2030 | $0.0934 | $0.0972 | $0.096 | +53.13% |
| March, 2030 | $0.0872 | $0.0991 | $0.091 | +42.90% |
| April, 2030 | $0.1156 | $0.084 | $0.1089 | +89.51% |
| May, 2030 | $0.1176 | $0.1084 | $0.1042 | +92.84% |
| June, 2030 | $0.1094 | $0.1196 | $0.1149 | +79.42% |
| July, 2030 | $0.1087 | $0.1154 | $0.1119 | +78.19% |
| August, 2030 | $0.0966 | $0.1067 | $0.103 | +58.37% |
| September, 2030 | $0.093 | $0.0931 | $0.0962 | +52.45% |
| October, 2030 | $0.11 | $0.0983 | $0.1195 | +80.31% |
| November, 2030 | $0.1261 | $0.1346 | $0.1251 | +106.76% |
| December, 2030 | $0.1205 | $0.127 | $0.1218 | +97.46% |
0.12%
0.08%
Cap:
|
Volume (24h):